Dermatology

In this analysis, the investigators sought to assess the ability of a ChatGPT-4-based chatbot in its performance of key functions in a teledermatology platform.

These data highlight current applications of AI and machine learning in aesthetic medicine, looking specifically at studies graded as Level I or II.

UCB announced that a new dosing option for bimekizumab-bkzx is now available through prescription for conditions such as psoriasis, hidradenitis suppurativa, and psoriatic arthritis.

This study pointed to the abilities of patients with acne to adapt to stress and adversity as helpful in making skin-related quality of life improvements.

This analysis is described as the first to identify predictive factors of oral candidiasis in individuals with psoriasis who are treated with bimekizumab.

These findings suggest that zinc and vitamin D levels may function as a disease severity indicator for patients with alopecia areata.

These data highlight the long-term efficacy of baricitinib, a JAK 1/2 inhibitor, for patients with severe alopecia areata in a real-world setting.

In this study, investigators pointed to existing resources available for mental health care among those with various skin conditions.

This analysis highlights the transcriptomic patterns of chronic hand eczema, indicating the potential of novel drug targets.

These findings highlight the value in understanding and recognizing gender differences in patient experiences with hidradenitis suppurativa and their impact on life quality.

New topline data released by Inmagene indicate positive findings from a phase 2a trial on IMG-007 for moderate-to-severe atopic dermatitis.

In this analysis, investigators highlighted various disease-related views and experiences dermatologists may wish to consider among Latine patients with psoriasis.

Patients in this post-hoc analysis with elevated CRP were found to have a higher BMI and more severe hidradenitis suppurativa.

This analysis using worldwide data from GBD 2021 indicates that the global burden of eczema in children has gradually risen and has been projected to continue increasing.

In this analysis, a retrospective and multi-center study was conducted to determine any predictors of biological therapy intensification in individuals with HS.

These data highlight the connection between obesity, nutrition habits, and psycho-emotional status to the etiopathogenesis of seborrheic dermatitis.

This study’s investigators examined long-term risk of dementia and Alzheimer’s dementia in patients with psoriasis, highlighting several notable findings.

These data highlight long-term complications related to COVID-19 in terms of skin conditions, a continuing concern for many patients.

To celebrate the close of 2024, we're recapping the 10 most popular approval articles across the HCPLive Network of brands.

The field of dermatology saw a wide array of notable developments this year, with highlights including FDA approvals as well as notable clinical trial results.

From groundbreaking therapies to ethical dilemmas, HCPLive’s top podcasts of 2024 delivered expert insights and human stories across medicine.

In this case–control study, investigators identified relevant comorbidities among individuals with bullous pemphigoid before and after their diagnoses.

These data resulted from an investigation of the effect of varying image qualities on the diagnostic abilities of a convolutional neural network (CNN) model and clinicians.

In a recent study, tralokinumab demonstrates effectiveness and safety for treating moderate-to-severe atopic dermatitis in adults who are dupilumab naïve and non-naïve.

Findings suggest an association between food allergies and atopic dermatitis control and persistence.

A study showed parents of children with atopic dermatitis have an increased odds of taking medication to aid sleep.

Study findings suggest an interplay between social determinants of health and HS, especially among underrepresented patient populations.

These long-term results from the ADjoin trial show that long-term lebrikizumab therapy may improve sleep disturbances, pruritus, and skin symptoms, using POEM as an assessment tool.

Investigators looked at the effects of the exposome among patients with atopic dermatitis in order to better understand the influence of such elements as obesity and microorganisms.